As the clinical trial industry continues to evolve and grow, so must clinical research professionals — now and in the future. At Javara, we recognize the importance of building the next generation of clinical research professionals and we’re not alone. Organizations like The Association of Clinical Research Professionals (ACRP), are leading initiatives to expand the…
Read MoreOn the Highway to Access: Innovation in Awareness, Education and Transportation in Clinical Research
Lack of reliable transportation has increasingly become a barrier to patients having access to and receiving consistent healthcare. In the span of a year, it costs the United States’ healthcare system more than $150 billion as a result of missed patient appointments. The burden of missing an appointment often leads to frustration and dissatisfaction when…
Read MoreHarvard Business Review reports that 26% of patients who face chronic or serious conditions have a low understanding of how to navigate the healthcare system. Similar to a complex healthcare system, the clinical trial process can be overwhelming to prospective research participants. Javara believes there is a solution, the Clinical Trial Navigator (CTN). Historically, this…
Read MoreClinical research as a care option was founded on the premise of integrating clinical research as part of the patient care continuum to enhance health outcomes, reduce costs, and enhance the patient and provider experience. The CRAACO Conference provides a space for individuals to learn more about why we should deploy clinical research as a…
Read MoreNearly 90 million people in the U.S. have difficulty understanding and acting upon health information, which affects their ability to make informed healthcare decisions. Health literacy affects an array of medical decisions, from dietary choices, to major decisions like which cancer treatment plan to pursue. People everyday make decisions about their health or the health…
Read MoreIt’s no secret pharmaceutical companies face a long, uphill battle to bring new drugs to market. And one of the biggest challenges is finding and engaging the right clinical trial participants. In fact, almost half of all clinical trials are delayed because of patient enrollment issues. And a staggering 94% of trials aren’t completed on…
Read MoreFor the past few years, value-based healthcare has been on everyone’s mind. The shift away from fee-for-service and towards value-based payment models in healthcare isn’t happening overnight, but there is a steady growth of momentum as more and more providers and health systems make the change to value. What are the opportunities as we consider…
Read MoreAs healthcare costs continue to rise, there is much discussion around how we pay for the services and treatments we receive. Traditionally, physicians and providers have been compensated through a fee-for-service model, leading some to ask if we are getting the level of care and outcomes commensurate with ever-increasing healthcare spending. Within this fee-for-service model,…
Read More
DPharm 2018 was all about a community of innovators coming together to discuss their disruptive ideas that will transform the norm of clinical research and biopharma development ultimately, to the benefit of patients. It’s clear as we look throughout the world around us, the pace of innovation is accelerating. What it affects is not selective…
Read MoreRight now, over 2 million patient volunteers in the United States are participating in clinical trials. Although this may seem like more than enough patient volunteers to meet the needs of the existing clinical trials in the United States, 2 million patient volunteers do not come close to the 58 million patient volunteers needed. Many…
Read More